Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Author(s) -
Myron S. Cohen,
Ying Qing Chen,
Marybeth McCauley,
Theresa Gamble,
Mina C. Hosseinipour,
Nagalingeswaran Kumarasamy,
James Hakim,
Johnstone Kumwenda,
Beatriz Grinsztejn,
José Henrique Pilotto,
Sheela Godbole,
Sanjay Mehendale,
Suwat Chariyalertsak,
Breno Santos,
Kenneth H. Mayer,
Irving Hoffman,
Susan H. Eshleman,
Estelle PiwowarManning,
Lei Wang,
Joseph Makhema,
Lisa A. Mills,
Guy de Bruyn,
Ian Sanne,
Joseph J. Eron,
Joel E. Gallant,
Diane V. Havlir,
Susan Swindells,
Heather J. Ribaudo,
Vanessa Elharrar,
David Burns,
Taha E. Taha,
Karin NielsenSaines,
David D. Celentano,
Max Essex,
Thomas R. Fleming
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1105243
Subject(s) - medicine , hazard ratio , serodiscordant , confidence interval , incidence (geometry) , antiretroviral therapy , transmission (telecommunications) , tuberculosis , viral load , rate ratio , human immunodeficiency virus (hiv) , pediatrics , immunology , pathology , physics , electrical engineering , optics , engineering
Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom